Physician profile
Mark A Perlmutter
NPI 1154511012
$5,357.05
in general payments reported to CMS, 2019-2025
50 companies · $985 in 2025
The $985 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $326 · 2021: $683 · 2022: $804 · 2023: $901 · 2024: $972 · 2025: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,858.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $587.33 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $373.31 | 2019-2025 | Erleada, Balversa, Akeega |
| Astellas Pharma US INC | $308.04 | 2019-2025 | Xtandi |
| Abbvie INC. | $291.28 | 2021-2025 | |
| Edap Technomed INC | $280.59 | 2024-2025 | |
| Pfizer INC. | $272.78 | 2019-2024 | |
| Myriad Genetic Laboratories, INC. | $272.12 | 2021-2024 | Prolaris |
| Calyxo, INC. | $235.84 | 2025 | Cvac Aspiration System |
| Tolmar, INC. | $210.99 | 2023-2025 | Eligard |
| Myovant Sciences INC. | $176.62 | 2021-2022 | |
| Urogen Pharma, INC. | $157.98 | 2021-2025 | Jelmyto |
| Teleflex LLC | $140.40 | 2021-2023 | Urolift |
| Medtronic, INC. | $132.57 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.27 | 2019-2023 | |
| Foundation Medicine, INC. | $122.53 | 2022-2023 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $113.29 | 2019-2020 | |
| Medtronic USA, INC. | $106.35 | 2019 | |
| Merck Sharp & Dohme LLC | $93.54 | 2022-2024 | Keytruda, Lynparza |
| Telix Pharmaceuticals | $89.62 | 2024-2025 | Illuccix |
| Boston Scientific Corporation | $87.64 | 2019-2025 | Spaceoar System |
| Coloplast Corp | $85.72 | 2019-2025 | Speedicath |
| Progenics Pharmaceuticals, INC. | $82.92 | 2023-2025 | Pylarify |
| Antares Pharma, INC. | $80.06 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $76.51 | 2023-2025 | Orgovyx, Gemtesa |
| Immunitybio, INC. | $67.81 | 2024-2025 | |
| 180 Medical, INC. | $67.29 | 2019-2023 | |
| Accord Healthcare, INC. | $53.58 | 2023-2025 | |
| Verity Pharmaceuticals INC. | $50.50 | 2025 | Trelstar |
| Olympus America INC. | $50.36 | 2021-2025 | Itind System |
| Novartis Pharmaceuticals Corporation | $50.30 | 2024-2025 | |
| Civco Medical Instruments | $48.02 | 2025 | |
| Corcept Therapeutics | $39.95 | 2023 | Korlym |
| Endo Pharmaceuticals INC. | $39.52 | 2019 | |
| Palette Life Sciences, INC. | $36.26 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $36.13 | 2023-2024 | Bard Urinary Drainage Bag |
| Gilead Sciences, INC. | $35.14 | 2023 | |
| Photocure INC | $30.03 | 2023-2025 | Cysview |
| Aytu Biopharma, INC. | $26.86 | 2019 | |
| Agiliti Surgical, INC. | $26.15 | 2024 | Sonablate Hifu, Dornier Thulio |
| Tolmar Pharmaceuticals, INC. | $25.56 | 2020-2021 | |
| Dentsply Ih Ab | $23.45 | 2024 | Lofric |
| Bioprotect Medical, INC. | $23.00 | 2025 | Bioprotect Balloon Implant System |
| Allergan, INC. | $22.65 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.10 | 2024 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $14.09 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.84 | 2022 | |
| Laborie Medical Technologies Corp. | $13.65 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $13.54 | 2022 | |
| Dentsply Ih INC. | $12.40 | 2021 | |
| Blue Earth Diagnostics | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Perlmutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.